"Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy Cl vs N Phys Trial
"Unequivocally Abnormal" vs "Usual" Signs and Symptoms for Proficient Diagnosis of Diabetic Polyneuropathy Cl vs N Phys Trial
复制标题
DOI:
10.1001/archneurol.2012.1481
复制
发表时间:
2012-12-01
影响因子:
--
通讯作者:
Vella, Adrian
中科院分区:
文献类型:
--
作者:
Dyck, Peter J.;Overland, Carol J.;Vella, Adrian
Objective: To repeat the Clinical vs Neurophysiology (Cl vs N Phys) trial using "unequivocally abnormal" signs and symptoms (Trial 2) compared with the earlier trial (Trial 1), which used "usual" signs and symptoms.Design: Standard and referenced nerve conduction abnormalities were used in both Trials 1 and 2 as the standard criterion indicative of diabetic sensorimotor polyneuropathy. Physician proficiency (accuracy among evaluators) was compared between Trials 1 and 2.Setting: Academic medical centers in Canada, Denmark, England, and the United States.Participants: Thirteen expert neuromuscular physicians. One expert was replaced in Trial 2.Results: The marked overreporting, especially of signs, in Trial 1 was avoided in Trial 2. Reproducibility of diagnosis between days 1 and 2 was significantly (P=.005) better in Trial 2. The correlation of the following clinical scores with composite nerve conduction measures spanning the range of normality and abnormality was improved in Trial 2: pinprick sensation (P=.03), decreased reflexes (P=.06), touch-pressure sensation (P=.06), and the sum of symptoms (P=.06).Conclusions: The simple pretrial decision to use unequivocally abnormal signs and symptoms-taking age, sex, and physical variables into account-in making clinical judgments for the diagnosis of diabetic sensorimotor polyneuropathy (Trial 2) improves physician proficiency compared with use of usual elicitation of signs and symptoms (Trial 1); both compare to confirmed nerve conduction abnormality. Arch Neurol. 2012; 69(12): 1609-1614. Published online September 17, 2012. doi:10.1001/archneurol.2012.1481